SureTrader SureTrader
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
 
Followed By 1,110
Posts 143,448
Boards Moderated 5
Alias Born 01/25/09
160x600 placeholder
PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator "GlobeNewswire Inc." - 12/7/2016 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 12/2/2016 5:29:05 PM
PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial "Marketwired" - 12/1/2016 9:00:00 AM
PharmaCyte Biotech Granted FDA Pre-IND Meeting for Pancreatic Cancer Therapy "GlobeNewswire Inc." - 11/29/2016 9:00:00 AM
PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial "Marketwired" - 11/16/2016 9:15:00 AM
University of Northern Colorado Presenting PharmaCyte Biotech’s Cannabis Research at the 2017 American Chemical Society Nat... "GlobeNewswire Inc." - 11/14/2016 9:00:00 AM
PharmaCyte Biotech Requests Pre-IND Meeting with FDA for its Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 11/1/2016 9:00:00 AM
PharmaCyte Biotech Selects Dr. Manuel Hidalgo as Principal Investigator for Its Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 10/24/2016 9:00:00 AM
PharmaCyte Biotech Cannabinoid Research Shows Promise for Success "GlobeNewswire Inc." - 10/10/2016 9:20:00 AM
PharmaCyte’s CEO Discusses Development of its Pancreatic Cancer Therapy "GlobeNewswire Inc." - 9/15/2016 9:15:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/6/2016 5:23:24 PM
PharmaCyte Biotech Reports on Progress in Its Medical Cannabis Program "GlobeNewswire Inc." - 9/1/2016 9:15:00 AM
Friendable, Inc. (OTC Pink: FDBL) Completes Upgrades for Monetization – Hits Number 1 in Apple App Store! "InvestorsHub NewsWire" - 8/23/2016 7:00:00 AM
Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum "GlobeNewswire Inc." - 8/2/2016 9:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 7/29/2016 5:27:49 PM
PharmaCyte Biotech Releases Shareholder Call Playback Information "GlobeNewswire Inc." - 7/29/2016 9:00:00 AM
PharmaCyte Biotech Shareholder Call Update "GlobeNewswire Inc." - 7/25/2016 9:00:00 AM
As Diabetes Becomes Global Epidemic, PharmaCyte Biotech's Insulin Producing Cells Receive 20 Years of Protection "Marketwired" - 7/19/2016 9:00:00 AM
Extraction Technology Becoming Paramount In Cannabis Industry as Consumers Gravitate Towards Concentrates And Higher Quality of "InvestorsHub NewsWire" - 7/19/2016 8:30:00 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 7/14/2016 4:02:03 PM
PharmaCyte Biotech Receives Patent Protection of the Melligen Cells to Treat Diabetes "GlobeNewswire Inc." - 7/14/2016 9:00:00 AM
PharmaCyte Biotech to Hold Shareholder Call "GlobeNewswire Inc." - 7/11/2016 9:00:00 AM
PharmaCyte Biotech Uses "Artificial Liver" to Treat Advanced Pancreatic Cancer "Marketwired" - 7/7/2016 9:00:00 AM
PharmaCyte’s Research on Medical Uses of Cannabinoids Supported by Recent Scientific Article "GlobeNewswire Inc." - 7/5/2016 9:40:25 AM
PharmaCyte Biotech CEO Interviewed by Small Cap Nation "GlobeNewswire Inc." - 6/28/2016 12:31:59 PM
NYC Trader   Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 56944 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA


Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist